\u00ab Une mission conjointe de l\u2019initiative Team Europe pour la production et l\u2019acc\u00e8s aux vaccins, m\u00e9dicaments et technologies de sant\u00e9 en Afrique (\u00ab MAV+ \u00bb) est au S\u00e9n\u00e9gal pour un dialogue approfondi avec les acteurs du secteur, publics et priv\u00e9s. <\/p>\n\n\n\n
Dans le cadre de cette mission, l\u2019Union europ\u00e9enne (UE) et l\u2019Allemagne ont annonc\u00e9 un appui financier suppl\u00e9mentaire de 36 milliards FCFA (55 millions d\u2019euros) pour un accompagnement \u00e0 360\u00b0 de l\u2019industrie pharmaceutique. Cet appui financier est un don non remboursable \u00bb, cette annonce est d\u2019un communiqu\u00e9 du bureau de la d\u00e9l\u00e9gation de l\u2019Union europ\u00e9enne \u00e0 Dakar. <\/p>\n\n\n\n
Selon la source, \u00ab ces moyens suppl\u00e9mentaires doivent renforcer l\u2019\u00e9cosyst\u00e8me n\u00e9cessaire au d\u00e9ploiement d\u2019une industrie pharmaceutique. Il s\u2019agit notamment du renforcement des comp\u00e9tences dans la fabrication de produits biologiques et dans la Recherche et D\u00e9veloppement, ou encore de l\u2019appui \u00e0 la dynamique priv\u00e9e, et en particulier celle du secteur priv\u00e9 europ\u00e9en, gr\u00e2ce \u00e0 un environnement d\u2019investissement plus favorable \u00bb. <\/p>\n\n\n\n
L\u2019Union europ\u00e9enne explique en outre que, \u00ab cet appui s\u2019ajoute au financement de plus de 107 milliards FCFA (163 millions d\u2019euros) d\u00e9j\u00e0 apport\u00e9s par la Team Europe (UE, Banque Europ\u00e9enne d\u2019Investissement, Allemagne, Belgique, France et Luxembourg), pour appuyer le plan de relance de l\u2019industrie pharmaceutique du S\u00e9n\u00e9gal, et notamment la construction et l\u2019\u00e9quipement de la plateforme de production de vaccins Madiba port\u00e9e par l\u2019Institut Pasteur de Dakar \u00bb.<\/p>\n\n\n\n
Fatou NDIAYE<\/p>\n\n\n\n
SUDQUOTIDIEN <\/p>\n","protected":false},"excerpt":{"rendered":"
\u00ab Une mission conjointe de l\u2019initiative Team Europe pour la production et l\u2019acc\u00e8s aux vaccins, m\u00e9dicaments et technologies de sant\u00e9<\/p>\n","protected":false},"author":1,"featured_media":24302,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-24301","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event-more-news"],"_links":{"self":[{"href":"https:\/\/dekkbi.com\/index.php?rest_route=\/wp\/v2\/posts\/24301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dekkbi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dekkbi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dekkbi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dekkbi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24301"}],"version-history":[{"count":1,"href":"https:\/\/dekkbi.com\/index.php?rest_route=\/wp\/v2\/posts\/24301\/revisions"}],"predecessor-version":[{"id":24303,"href":"https:\/\/dekkbi.com\/index.php?rest_route=\/wp\/v2\/posts\/24301\/revisions\/24303"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dekkbi.com\/index.php?rest_route=\/wp\/v2\/media\/24302"}],"wp:attachment":[{"href":"https:\/\/dekkbi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dekkbi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dekkbi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}